These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1305686)

  • 1. Pathology of carcinoma in situ of the urinary bladder and related lesions.
    Farrow GM
    J Cell Biochem Suppl; 1992; 16I():39-43. PubMed ID: 1305686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
    McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraepithelial lesions of urinary bladder: morphologic considerations.
    Murphy WM; Busch C; Algaba F
    Scand J Urol Nephrol Suppl; 2000; (205):67-81. PubMed ID: 11144906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.
    Nese N; Gupta R; Bui MH; Amin MB
    J Natl Compr Canc Netw; 2009 Jan; 7(1):48-57. PubMed ID: 19176205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
    Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
    J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee.
    van der Meijden A; Oosterlinck W; Brausi M; Kurth KH; Sylvester R; de Balincourt C
    Eur Urol; 1999 Apr; 35(4):267-71. PubMed ID: 10419345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies.
    Montironi R; Lopez-Beltran A; Mazzucchelli R; Bostwick DG
    J Clin Pathol; 2003 Feb; 56(2):91-5. PubMed ID: 12560385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.
    Schned AR; Andrew AS; Marsit CJ; Kelsey KT; Zens MS; Karagas MR
    Scand J Urol Nephrol; 2008; 42(3):237-42. PubMed ID: 18432530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of upper tract urothelial carcinoma with emphasis on staging.
    Mazzucchelli R; Scarpelli M; Galosi AB; Di Primio R; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2014; 27(4):509-16. PubMed ID: 25572730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
    Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
    Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of superficial bladder cancer with emphasis on carcinoma in situ.
    Weinstein RS; Coon JS; Schwartz D; Miller AW; Pauli BU
    Urology; 1985 Oct; 26(4 Suppl):2-10. PubMed ID: 3901485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.